Cotización Renovacor - RCOR

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Último Precio

3.20

Postura de Compra

Postura de Venta

Volume Operado de la Acción

0.00 Rango del Día 0.00

0.00 Rango de 52 semanas 0.00

Precio Anterior

3.20

Precio de Apertura

Hora

Última hora de negociación

Volumen promedio (3 m)

Volumen financiero

Precio Promedio Ponderado

Renovacor Announces Upcoming Presentation at the 29th European Society of Gene & Cell Therapy Congress

Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular...

Renovacor Announces Upcoming Presentation at Keystone Symposia’s Heart Failure: Mechanisms and Therapies Conference

Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular...

Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene Therapy

Acquisition further strengthens Rocket’s leadership in AAV-based cardiac gene therapy and expands Company’s near-term clinical assets for the treatment of heart conditions Significant unmet...

Renovacor Reports Second Quarter 2022 Financial Results and Provides Corporate Update

REN-001 IND submission planned for the second half of 2022 Data from pilot pig study showing successful cardiac transduction with REN-001 delivered via low-dose retrograde coronary sinus...

Renovacor Announces Pipeline Expansion with New Research Program for Multiple Genetic Segments of Arrhythmogenic Cardiomyopathy

Research collaboration with the University of Utah's Nora Eccles Harrison Cardiovascular Research and Training Institute expands pipeline with the addition of an AAV gene therapy program for...

Renovacor Announces Data from Pilot Pig Study Showing Successful Cardiac Transduction with REN-001 Delivered Via Low-Dose Retrograde Coronary Sinus Infusion Published in Journal of the American College of Cardiology: Basic to Translational Research

REN-001 delivered locally via low-dose retrograde coronary sinus infusion demonstrated robust, diffuse cardiomyocyte transduction in a large animal heart Renovacor, Inc. (NYSE: RCOR), a...

Renovacor Reports First Quarter 2022 Financial Results and Provides Corporate Update

REN-001 advancing toward IND submission in the second half of 2022 with the initiation of a Phase I/II clinical trial in BAG3-DCM expected thereafter Strengthened executive team with appointment...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

RCOR - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Renovacor?

El precio actual de las acciones de Renovacor es US$ 3.20

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Renovacor?

Renovacor ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
CTMCastellum Inc	US$ 0.992 (29.96%)	13.83M
AZTRAzitra Inc	US$ 0.3837 (26.22%)	22.93M
TOPPToppoint Holdings Inc	US$ 2.15 (25.73%)	186.29k
DITAMCON Distributing Co	US$ 149.10 (15.72%)	3.4k
PTNPalatin Technologies Inc New	US$ 0.99995 (15.47%)	19.05M
EVXVanEck Environmental Services ETF	US$ 35.81 (-79.84%)	14.88k
SGNSigning Day Sports Inc	US$ 2.96 (-13.20%)	350.86k
AMBOAmbow Education Holding Ltd	US$ 2.53 (-11.23%)	11.47k
MYNDMynd ai Inc	US$ 1.115 (-10.80%)	62.72k
ATCHAtlasClear Holdings Inc	US$ 3.45 (-10.62%)	100.63k
TSLZT Rex 2X Inverse Tesla Daily Target ETF	US$ 2.665 (2.11%)	70.69M
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 27.69 (-0.04%)	59.74M
SPXSDirexion Daily S&P 500 Bear 3X Shares New	US$ 5.715 (-0.95%)	49.65M
ETHU2x Ether ETF	US$ 4.55 (-3.09%)	41.17M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF	US$ 3.07 (-5.54%)	39.98M